Guj. Terce Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE499G01013
  • NSEID:
  • BSEID: 524314
INR
37.56
3.6 (10.6%)
BSENSE

Jun 18

BSE+NSE Vol: 8.09 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Murae Organisor
Guj. Terce Labs.
Parmax Pharma
Ishita Drugs
Medi Caps
Venmax Drugs
Welcure Drugs
Shree Ganesh Bio
Lasa Supergeneri
Chandra Bhagat
Medicamen Organ.
Why is Gujarat Terce Laboratories Ltd ?
1
Weak Long Term Fundamental Strength with a 9.05% CAGR growth in Net Sales over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.37
2
With ROE of -13.6, it has a Very Expensive valuation with a 4.4 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -40.94%, its profits have fallen by -139.1%
3
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 2.26% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -40.94% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Guj. Terce Labs. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Guj. Terce Labs.
-33.5%
-0.64
64.09%
Sensex
-5.14%
0.43
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
13.52%
EBIT Growth (5y)
25.66%
EBIT to Interest (avg)
1.21
Debt to EBITDA (avg)
0.73
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
4.64
Tax Ratio
26.97%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
30.11%
ROE (avg)
7.71%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
11
Industry P/E
34
Price to Book Value
2.71
EV to EBIT
7.06
EV to EBITDA
6.25
EV to Capital Employed
3.45
EV to Sales
0.50
PEG Ratio
0.03
Dividend Yield
NA
ROCE (Latest)
48.83%
ROE (Latest)
25.13%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company
PAT(Latest six months)

Higher at Rs 1.09 cr

-1What is not working for the Company
NET SALES(Q)

At Rs 11.40 cr has Fallen at -5.8% (vs previous 4Q average

Loading Valuation Snapshot...
Here's what is working for Guj. Terce Labs.
Profit After Tax (PAT) - Latest six months
At Rs 1.09 cr has Grown at 145.59%
Year on Year (YoY)
MOJO Watch
PAT trend is very positive

PAT (Rs Cr)

Profit After Tax (PAT) - Latest six months
Higher at Rs 1.09 cr
than preceding 12 month period ended Mar 2026 of Rs -1.02 cr
MOJO Watch
In the half year the company has already crossed PAT of the previous twelve months

PAT (Rs Cr)

Here's what is not working for Guj. Terce Labs.
Net Sales - Quarterly
At Rs 11.40 cr has Fallen at -5.8% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 12.10 Cr
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)